A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Eligible age
10–18 yrs
Accepts
All genders
Locations
14 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, and in the second part participant will get CagriSema. In the first part, which treatment participant gets is decided by chance and second part is open label and all participants will get CagriSema during this part. The study will last for about 1 year and 3 months.
Sponsor: Novo Nordisk A/S
Where it's recruiting
New Haven
Boynton Beach · Jacksonville · Kissimmee · Tamarac …
Columbus · Snellville
Springfield
Indianapolis
Iowa City
Southfield
Buffalo · New York
Philadelphia
Rapid City
Memphis
Houston · Shavano Park
Source: ClinicalTrials.gov · NCT07282613 · last updated 2026-09-09